BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33477402)

  • 1. Gene Methylation and Silencing of WIF1 Is a Frequent Genetic Abnormality in Mantle Cell Lymphoma.
    Alshareef A; Peters AC; Gélébart P; Chen W; Lai R
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix.
    Delmas AL; Riggs BM; Pardo CE; Dyer LM; Darst RP; Izumchenko EG; Monroe M; Hakam A; Kladde MP; Siegel EM; Brown KD
    Carcinogenesis; 2011 Nov; 32(11):1625-33. PubMed ID: 21873353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas.
    Chan SL; Cui Y; van Hasselt A; Li H; Srivastava G; Jin H; Ng KM; Wang Y; Lee KY; Tsao GS; Zhong S; Robertson KD; Rha SY; Chan AT; Tao Q
    Lab Invest; 2007 Jul; 87(7):644-50. PubMed ID: 17384664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WIF1 promoter hypermethylation induce endometrial carcinogenesis through the Wnt/β-catenin signaling pathway.
    Zhang B; Ji J; Hu M; Zhou X; Nie Q; Xu H; Jiang C; Fu Y; Li L
    Am J Reprod Immunol; 2023 Aug; 90(2):e13743. PubMed ID: 37491917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylation of WNT inhibitory factor-1 and expression pattern of WNT/β-catenin pathway in human astrocytoma: pathologic and prognostic correlations.
    Kim SA; Kwak J; Nam HY; Chun SM; Lee BW; Lee HJ; Khang SK; Kim SW
    Mod Pathol; 2013 May; 26(5):626-39. PubMed ID: 23328978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma.
    Gelebart P; Anand M; Armanious H; Peters AC; Dien Bard J; Amin HM; Lai R
    Blood; 2008 Dec; 112(13):5171-9. PubMed ID: 18787224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of Wnt inhibitory factor-1 in human esophageal squamous cell carcinoma.
    Yang SH; Li SL; Dong ZM; Kan QC
    Oncol Res; 2012; 20(2-3):123-30. PubMed ID: 23193918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
    Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
    Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma.
    Liu P; Shen JK; Hornicek FJ; Liu F; Duan Z
    Sci Rep; 2017 May; 7(1):1580. PubMed ID: 28484252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The negative regulators of Wnt pathway-DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival.
    Paluszczak J; Sarbak J; Kostrzewska-Poczekaj M; Kiwerska K; Jarmuż-Szymczak M; Grenman R; Mielcarek-Kuchta D; Baer-Dubowska W
    Tumour Biol; 2015 Apr; 36(4):2855-61. PubMed ID: 25487617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence.
    Lambiv WL; Vassallo I; Delorenzi M; Shay T; Diserens AC; Misra A; Feuerstein B; Murat A; Migliavacca E; Hamou MF; Sciuscio D; Burger R; Domany E; Stupp R; Hegi ME
    Neuro Oncol; 2011 Jul; 13(7):736-47. PubMed ID: 21642372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide exhibits antitumor effects by reversing hypermethylation of WIF‑1 in lung cancer cells.
    Mao X; Tong J; Wang Y; Zhu Z; Yin Y; Wang Y
    Mol Med Rep; 2018 Sep; 18(3):3041-3049. PubMed ID: 30015908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WIF1 was downregulated in cervical cancer due to promoter methylation.
    Wang Y; Yuan S; Ma J; Liu H; Huang L; Zhang F; Wang X
    Acta Biochim Pol; 2023 Jun; 70(2):419-423. PubMed ID: 37306343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence.
    Ramachandran I; Ganapathy V; Gillies E; Fonseca I; Sureban SM; Houchen CW; Reis A; Queimado L
    Cell Death Dis; 2014 May; 5(5):e1246. PubMed ID: 24853424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor.
    Mitsui Y; Yasumoto H; Nagami T; Hiraki M; Arichi N; Ishikawa N; Araki A; Maruyama R; Tanaka Y; Dahiya R; Shiina H
    Oncotarget; 2014 Apr; 5(8):2198-207. PubMed ID: 24755523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling.
    Chung J; Karkhanis V; Baiocchi RA; Sif S
    J Biol Chem; 2019 May; 294(19):7692-7710. PubMed ID: 30885941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.
    Chim CS; Pang R; Fung TK; Choi CL; Liang R
    Leukemia; 2007 Dec; 21(12):2527-36. PubMed ID: 17882284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer.
    Zhao Z; Liu W; Liu J; Wang J; Luo B
    J Med Virol; 2017 Oct; 89(10):1844-1851. PubMed ID: 28543390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.
    Ripperger T; von Neuhoff N; Kamphues K; Emura M; Lehmann U; Tauscher M; Schraders M; Groenen P; Skawran B; Rudolph C; Callet-Bauchu E; van Krieken JH; Schlegelberger B; Steinemann D
    Haematologica; 2007 Apr; 92(4):460-8. PubMed ID: 17488656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.